Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 3 | 5 | 2021 | 351 | 1.280 |
Why?
|
| Virus Latency | 4 | 2021 | 64 | 0.970 |
Why?
|
| HIV-1 | 5 | 2021 | 489 | 0.810 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2562 | 0.720 |
Why?
|
| Histone Code | 2 | 2017 | 53 | 0.660 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 237 | 0.600 |
Why?
|
| Histones | 2 | 2017 | 572 | 0.510 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 51 | 0.480 |
Why?
|
| Phosphorylation | 3 | 2018 | 1713 | 0.410 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 559 | 0.380 |
Why?
|
| DNA | 1 | 2016 | 1684 | 0.330 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2017 | 136 | 0.300 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 504 | 0.230 |
Why?
|
| Trophoblasts | 1 | 2025 | 122 | 0.220 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2025 | 211 | 0.210 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2021 | 7 | 0.180 |
Why?
|
| Cell Movement | 1 | 2025 | 920 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 2137 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 507 | 0.150 |
Why?
|
| HIV Infections | 3 | 2021 | 2073 | 0.150 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2018 | 22 | 0.140 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.140 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 346 | 0.140 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 46 | 0.140 |
Why?
|
| Virus Activation | 1 | 2017 | 85 | 0.140 |
Why?
|
| Virus Integration | 1 | 2017 | 40 | 0.140 |
Why?
|
| Leukemia Virus, Murine | 2 | 2006 | 4 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 266 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 90 | 0.120 |
Why?
|
| Binding Sites | 2 | 2016 | 1386 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3800 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2771 | 0.110 |
Why?
|
| DNA Replication | 1 | 2016 | 359 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 469 | 0.100 |
Why?
|
| Chromatin | 1 | 2017 | 617 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2016 | 624 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 795 | 0.100 |
Why?
|
| Glucose | 1 | 2018 | 926 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 1761 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2021 | 4012 | 0.100 |
Why?
|
| Carnitine Acyltransferases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2012 | 116 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 827 | 0.090 |
Why?
|
| Cell Line | 4 | 2025 | 2863 | 0.090 |
Why?
|
| Humans | 13 | 2025 | 134145 | 0.080 |
Why?
|
| Cell Separation | 2 | 2006 | 233 | 0.080 |
Why?
|
| Mice | 4 | 2021 | 19044 | 0.080 |
Why?
|
| Retroviridae Infections | 1 | 2006 | 10 | 0.070 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2006 | 5 | 0.070 |
Why?
|
| Ribonucleases | 1 | 2006 | 51 | 0.060 |
Why?
|
| Animals | 6 | 2021 | 36520 | 0.060 |
Why?
|
| Lentivirus | 1 | 2006 | 86 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1853 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2006 | 967 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2016 | 4936 | 0.060 |
Why?
|
| Placentation | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3180 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 890 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2021 | 94 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 179 | 0.040 |
Why?
|
| Female | 4 | 2025 | 72004 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1135 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2018 | 46 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 42 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.040 |
Why?
|
| Chemokine CCL19 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Ionomycin | 1 | 2017 | 18 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2017 | 68 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 2017 | 5 | 0.040 |
Why?
|
| Piperidones | 1 | 2017 | 8 | 0.040 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2017 | 20 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 119 | 0.030 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 14 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 233 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 91 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 173 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 232 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 195 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 531 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2018 | 276 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 548 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 2538 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 824 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 745 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 1013 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 608 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 830 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 636 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 603 | 0.030 |
Why?
|
| Mutation | 3 | 2018 | 6341 | 0.030 |
Why?
|
| Ketosis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7600 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2012 | 62 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 468 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 193 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1922 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 60 | 0.020 |
Why?
|
| Systems Biology | 1 | 2010 | 63 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 127 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 329 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2012 | 372 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 389 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 283 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 416 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 207 | 0.020 |
Why?
|
| Phenotype | 2 | 2010 | 4605 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 352 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5084 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 385 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1783 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 564 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2017 | 2734 | 0.020 |
Why?
|
| Leupeptins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1436 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2006 | 111 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 100 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 396 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 1041 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 673 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 1043 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 912 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2006 | 633 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2010 | 700 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2669 | 0.010 |
Why?
|
| Male | 4 | 2012 | 66171 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2793 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3978 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 934 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4882 | 0.010 |
Why?
|